Dr. Manching Ku is a group leader at the Center for Pediatrics & Adolescent Medicine, University Hospital in Freiburg in Germany. Manching completed her Ph.D in Biochemistry at Tufts University studying transcriptional regulations in TGFb/ BMP pathways during development. She received her postdoctoral training at the Broad Institute of Harvard & MIT in the laboratory of Dr. Bradley Bernstein. During her time at the Broad Institute, in addition to spear-heading one of the first epigenomic studies that defined chromatin states in pluripotent and iPS cells, she also established the experimental pipelines for the Encyclopedia of DNA Elements (ENCODE) and Reference Epigenome Mapping Center (REMC) consortia. Dr. Ku started the Next-generation Sequencing core at the Salk Institute for Biological Sciences in 2013.